# T Cells Response to SARS COV 2 Peptides

> **NCT04573348** · — · UNKNOWN · sponsor: **Savicell Diagnostics Ltd** · enrollment: 400 (estimated)

## Conditions studied

- Covid19
- Corona Virus Infection

## Interventions

- **DIAGNOSTIC_TEST:** Savicell's ImmunoBiopsy™

## Key facts

- **NCT ID:** NCT04573348
- **Lead sponsor:** Savicell Diagnostics Ltd
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-10-14
- **Primary completion:** 2021-05-10
- **Final completion:** 2021-10-10
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2020-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04573348

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04573348, "T Cells Response to SARS COV 2 Peptides". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04573348. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*